Get the Stockscreener App
13.33
0.38%
0.05
Daxor Corporation stock is traded at $13.33, with a volume of 320.
It is up +0.38% in the last 24 hours and up +12.21% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$13.28
Open:
$13.3317
24h Volume:
320
Relative Volume:
0.01
Market Cap:
$64.48M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
44.39
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
+3.90%
1M Performance:
+12.21%
6M Performance:
+67.04%
1Y Performance:
+46.00%
1-Day Range:
$13.33
$13.33
1-Week Range:
$12.52
$13.33
52-Week Range:
$6.55
$14.00
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
13.33 | 66.19M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
458.48 | 164.35B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
189.62 | 54.75B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
268.22 | 39.61B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.26 | 37.31B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
276.59 | 19.77B | 2.96B | 487.70M | 344.00M | 6.6758 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Daxor Corporation to Participate in Exclusive Maxim Growth Summit Featuring 40 Promising Healthcare Companies - Quiver Quantitative
Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit - GlobeNewswire
Why analysts raise outlook for Daxor Corporation (DX5) stock2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Will Daxor Corporation (DX5) stock extend growth storyJuly 2025 Pullbacks & Weekly High Return Opportunities - newser.com
Will Daxor Corporation (DX5) stock outperform benchmarksJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Can technical indicators confirm Daxor Corporation’s reversalWeekly Trade Report & Detailed Earnings Play Strategies - newser.com
How Daxor Corporation (DX5) stock behaves under inflation pressure2025 Historical Comparison & Fast Entry High Yield Tips - nchmf.gov.vn
How strong is Daxor Corporation (DX5) stock earnings growthWeekly Stock Recap & Weekly High Return Forecasts - newser.com
Is Daxor Corporation (DX5) stock attractive for dividend growthMarket Risk Analysis & Fast Entry High Yield Tips - nchmf.gov.vn
Is Daxor Corporation stock a buy before product launchesPortfolio Value Summary & Weekly Consistent Profit Watchlists - newser.com
Can Daxor Corporation (DX5) stock retain market dominance2025 Trade Ideas & Reliable Intraday Trade Plans - newser.com
Why Daxor Corporation (DX5) stock could rally stronglyTrade Volume Summary & Fast Exit Strategy with Risk Control - newser.com
Chart overlay techniques for tracking Daxor Corporation2025 Valuation Update & Trade Opportunity Analysis Reports - newser.com
Sector ETF performance correlation with Daxor CorporationWeekly Profit Report & Fast Gaining Stock Reports - newser.com
What earnings revisions data tells us about Daxor Corporation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Will Daxor Corporation stock maintain dividend yieldJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Head-To-Head Comparison: Bioqual (OTCMKTS:BIOQ) and Daxor (NASDAQ:DXR) - Defense World
Is Daxor Corporation reversing from oversold territory2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com
Is Daxor Corporation stock poised for growthExit Point & Weekly Watchlist for Hot Stocks - newser.com
Can Daxor Corporation stock beat analyst upgradesPortfolio Value Summary & Weekly Return Optimization Plans - nchmf.gov.vn
Quarterly Risk: Is Daxor Corporation (DX5) stock undervalued by metricsWeekly Trend Recap & Safe Entry Trade Reports - nchmf.gov.vn
Daxor to exhibit at the MedAxiom CV Transforum Fall’25 Conference - MSN
Using data filters to optimize entry into Daxor CorporationIPO Watch & High Return Stock Watch Alerts - newser.com
Full technical analysis of Daxor Corporation stockDividend Hike & Weekly High Return Stock Forecasts - newser.com
Daxor (DXR) to Showcase at Cardiovascular Conference in Austin - GuruFocus
Daxor’s New BVA Technology To Be Showcased At MedAxiom CV Transforum Fall '25 - GlobeNewswire
Next‑Gen BVA System: Daxor Debuts Blood‑Volume Diagnostic at MedAxiom CV Transforum Oct 16–18 - Stock Titan
[N-CSR/A] – DAXOR CORP (DXR) (CIK 0000027367) | DXR SEC FilingForm N-CSR/A - Stock Titan
Using fundamentals and technicals on Daxor CorporationJuly 2025 WrapUp & Weekly Sector Rotation Insights - newser.com
Can Daxor Corporation stock sustain free cash flow growthJuly 2025 Intraday Action & Weekly Chart Analysis and Trade Guides - newser.com
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.93%
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):